The US Environmental Protection Agency has been ordered by an appeals court to re-examine the health risks of glyphosate. In San Francisco on Friday, the court ruled that the EPA’s assessment that the active ingredient in Bayer’s controversial weed killer Roundup poses no particular risk to humans is questionable. The EPA last reviewed the pesticide in 2020 and maintained that it posed no health risk when used correctly. In its ruling, the court was particularly bothered by the way the EPA justified that glyphosate is not carcinogenic. The underlying analysis is “incorrect” and is partly not in line with the guidelines of the authority. In a statement, Bayer expressed confidence that the EPA found no cancer risks from glyphosate even in a new review. There was also good news for the Dax company on Friday: In a case in the state of Oregon, it achieved another success in court. Bayer has now won the last four US lawsuits involving plaintiffs who blame glyphosate for cancer.
Glyphosate – US Environmental Protection Agency to review again – Economy
